Form 4: IDEAYA Biosciences Director Wendy Yarno Acquires Stock Options

IDEAYA Biosciences Director Wendy L. Yarno acquired 20,000 stock options with an exercise price of $30.57, vesting under specific conditions related to service and annual meetings.

Summary

• Director Wendy L. Yarno of IDEAYA Biosciences, Inc. (IDYA) acquired 20,000 stock options on June 16, 2026.
• The options have an exercise price of $30.57 per share.
• These options are subject to vesting conditions: 100% vest on the first anniversary of the grant date or immediately before the following Annual Meeting, provided the reporting person remains on the Board.
• The underlying securities are 20,000 shares of Common Stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a standard compensation mechanism for a director, aligning interests, but does not inherently signal new financial performance or strategic shifts.

Positives

• Director Wendy L. Yarno has acquired a significant number of stock options, indicating confidence in the company's future prospects.
• The acquisition of options aligns the director's interests with those of shareholders.
• The vesting schedule encourages continued service and commitment to the company.

Risks

• The value of the stock options is contingent on the future performance of IDEAYA Biosciences' stock price.
• Vesting is dependent on the reporting person continuing in service on the Board, which introduces a risk of forfeiture if service is terminated.
• The exercise price of $30.57 means the options will only be profitable if the stock price exceeds this level.

Future Outlook

The vesting schedule for the stock options suggests a forward-looking perspective, with full vesting contingent on continued service and company performance relative to the exercise price.

Industry Context

StockSavvy.ai notes that the granting of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors, aligning executive incentives with shareholder value creation and encouraging long-term commitment.

Stakeholder Impact

• Shareholders: The alignment of director incentives with shareholder value is generally positive. The success of the options depends on stock price appreciation.
• Employees: This filing does not directly impact employees but reflects standard compensation practices for leadership.
• Management: The director's compensation is structured to encourage continued service and performance.

Next Steps

• The director will continue to serve on the Board.
• The stock options will vest according to the specified schedule.
• The company's stock price will be monitored to determine the profitability of the options.

Key Dates

Keywords

IDEAYA Biosciences, IDYA, Form 4, Stock Options, Director, Beneficial Ownership, Securities, Vesting Schedule